Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Chris Carey has maintained an Equal-Weight rating on Colgate-Palmolive (NYSE:CL) and increased the price target from $90 to $92.
April 29, 2024 | 6:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Colgate-Palmolive and raised the price target from $90 to $92.
The increase in price target by Wells Fargo suggests a positive outlook on Colgate-Palmolive's future performance. This adjustment reflects an expectation of growth or stability in the company's stock price, likely due to favorable market conditions or company-specific factors. As the rating remains Equal-Weight, the adjustment is seen as a moderate endorsement of the stock's potential for growth, rather than a strong buy signal. Investors may view this as a sign of steady, albeit not spectacular, performance ahead.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100